GTCM
INSM icon

Gyon Technologies Capital Management’s Insmed INSM Stock Holding History

Gyon Technologies Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,940
Closed -$274K – 600
2021
Q3 		$274K Sell
9,940
-50,356
-84% -$1.32M 0.07% 304
2021
Q2 		$1.72M Buy
60,296
+52,129
+638% +$1.55M 0.56% 65
2021
Q1 		$278K Buy
+8,167
New +$312K 0.12% 294
2020
Q4 		– Sell
-15,989
Closed -$514K – 391
2020
Q3 		$514K Buy
+15,989
New +$460K 0.4% 96

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Gyon Technologies Capital Management's INSM Position: Q4 2021 in Review

Gyon Technologies Capital Management sold out of Insmed (INSM) in Q4 2021, closing a stake of 9,940 shares — an estimated $274K sold.

Gyon Technologies Capital Management first reported a position in INSM in Q3 2020 and held it in 4 quarters. The position peaked at $1.72M in Q2 2021. 214 funds tracked by Wall St. Rank hold INSM as of Q4 2021.

  • Gyon Technologies Capital Management reported no remaining Insmed position as of Q4 2021 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 9,940 Insmed shares in Q4 2021, an estimated $274K.
  • Gyon Technologies Capital Management first reported a position in Insmed in Q3 2020 and held it in 4 quarters.
  • Gyon Technologies Capital Management's Insmed position peaked at $1.72M in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Insmed as of Q4 2021.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.